missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TLE1 Monoclonal Antibody (381CT18.5.1)

Mouse Monoclonal Antibody
Brand: Invitrogen™ MA537542
This item is not returnable.
View return policy
Description
TLE1 Monoclonal Antibody for Western Blot
Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG.
Specifications
| TLE1 | |
| Monoclonal | |
| 0.4 mg/mL | |
| PBS with 0.09% sodium azide; pH 7.4 | |
| Q04724 | |
| TLE1 | |
| KLH conjugated synthetic peptide between 199-228 amino acids from the Central region of human TLE1. | |
| 400 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Western Blot | |
| 381CT18.5.1 | |
| Unconjugated | |
| TLE1 | |
| C230057C06Rik; E(Sp1) homolog; enhancer of split groucho; enhancer of split groucho-like protein 1; esg; ESG1; Estm14; grg1; Grg-1; Groucho-related protein 1; RP11-203D19.1; TLE 1; TLE1; tle1.S; tle3b; Tle4l; transducin like enhancer of split 1; transducin like enhancer of split 1 S homeolog; transducin-like enhancer of split 1 (E(sp1) homolog); transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila); transducin-like enhancer of split 1, homolog of Drosophila E(spl); transducin-like enhancer of split 3 (E(sp1) homolog) b; transducin-like enhancer of split 4 (homolog of Drosophila E(spl)) - like; transducin-like enhancer protein 1; XELAEV_18001139mg; xgrg1 | |
| Mouse | |
| Protein G | |
| RUO | |
| 7088 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction